Abeona Therapeutics (NasdaqCM:ABEO) Q3 2025 Earnings Call November 12, 2025 08:30 AM ET Company ParticipantsBrian Kevany - SVP, Chief Technical Officer, and Chief Scientific OfficerAmin Makarem - VP of Biotech Equity ResearchJoe Vazzano - CFORam Selvaraju - Managing DirectorGregory Gin - VP of Investor Relations and Corporate CommunicationsMadhav Vasanthavada - Chief Commercial OfficerVishwas Seshadri - CEOMatt Venezia - Equity Research Senior AssociateRick Miller - VP of Biotech Equity ResearcConference Ca ...

Abeona Therapeutics (NasdaqCM:ABEO) Q3 2025 Earnings Call November 12, 2025 08:30 AM ET Company ParticipantsBrian Kevany - SVP, Chief Technical Officer, and Chief Scientific OfficerJoe Vazzano - CFORam Selvaraju - Managing DirectorGregory Gin - VP of Investor Relations and Corporate CommunicationsMadhav Vasanthavada - Chief Commercial OfficerVishwas Seshadri - CEOConference Call ParticipantsNone - AnalystDavid Bautz - Senior AnalystNone - AnalystNone - AnalystNone - AnalystJeff Jones - Senior AnalystOperato ...

Abeona Therapeutics (NasdaqCM:ABEO) Q3 2025 Earnings Call November 12, 2025 08:30 AM ET Speaker1Good morning, everyone, and welcome to the Abeona Therapeutics third quarter 2025 conference call. At this time, all participants are in a listen-only mode, and the floor will be open for questions following the presentation. If anyone should require operator assistance during this conference, please press star zero on your phone keypad. Please note this conference is being recorded. I will now turn the conferenc ...